Targeted Pharmaceutical Patent Analysis

The patent system was designed to be  entrusted to authentic inventors and legitimate drug development organizations. However, many pharmaceutical filings are purposefully designed to artificially extend the reach of protection afforded by an efficient patent system.  We have developed a comprehensive and multifaceted process for identifying pharmaceutical filings that make a mockery of the patent system.  Once a potential candidate patent or patent group has been identified, we make every effort to expose those patents as neither unique nor useful. 

The unique approach to our solution lies in how the material we develop is ultimately leveraged after analysis. In addition to traditional solutions such as filing petitions for Inter Partes review, or other judicial remedies, our investigations can  sometimes benefit from public dissemination and distribution  in order for all concerned organizations and coalitions worldwide to expand and focus our initial analysis. We feel that, while our team generates some of the best and most comprehensive studies available in the industry, our work can only improve with public scrutiny in order that the information is used for defeating these patents. 

We are dedicated to improving durable and equitable competition in the prescription drug market, assuring fair and market-based pricing for all innovative and groundbreaking discoveries made by pharmaceutical companies that are beneficial to patients, physicians, and health care networks. We will fight for all who will benefit from fair and equitable drug pricing but we will challenge any entity abusing the process to increase their profits at the expense of these same  patients, physicians, and health care networks.